Food Allergy News
Latest News About Food Allergies and Related Conditions
AAFA can connect you to all of the information and resources you need. We provide the latest information about asthma and allergic diseases in a variety of formats. You can sign up to follow our blogs or receive our newsletters. To stay up to date on the Foundation’s announcements, check out our press releases as well.
If you are a member of the press, and need to speak with an asthma or allergy expert for your story, please contact a member of AAFA’s communications team at (202) 974-1223 or email gro.afaa@aidem.
Press Releases
Safer Skies Ahead: Congress Approves Legislation Requiring Updates to Airline Emergency Medical Kits
Get InvolvedLaw designates kits must be equipped to address anaphylaxis Washington, DC, May 15, 2024 – The Asthma and Allergy Foundation of America (AAFA) is celebrating Congressional action that could lead to safer skies for travelers with...
National Asthma and Allergy Awareness Month Empowers Individuals and Communities
Get InvolvedAAFA celebrates 40th year of May to raise awareness and save lives Washington, DC, April 30, 2024 – Since 1984, the Asthma and Allergy Foundation of America (AAFA) has designated May as National Asthma and Allergy Awareness Month. This...
Maryland Becomes Fourth State to Enact Elijah’s Law to Protect Kids with Food Allergies
Get InvolvedAAFA celebrates action to make child care centers safer Washington, DC, April 26, 2024 – The Asthma and Allergy Foundation of America (AAFA) celebrates the signing of Elijah’s Law in Maryland. The legislation, passed by the Maryland House...
AAFA Joins Advocates on Capitol Hill in Support of Dillon’s Law and Expanded Access to Epinephrine
Get InvolvedLaw would improve access to life-saving medical treatment Washington, D.C. – This week, the Asthma and Allergy Foundation of America (AAFA) is proud to join the unwavering advocacy efforts of Angel and George Mueller, parents of Dillon...
AAFA’s Statement Regarding the FDA Decision on Needle-Free Epinephrine Nasal Spray
Get InvolvedWashington D.C., September 20, 2023 — The Asthma and Allergy Foundation of America (AAFA) is disappointed that the epinephrine nasal spray known as neffy did not receive FDA approval but understands the agency is requesting additional...
New Study on the Current State of Health Care for Eosinophilic Esophagitis
Get InvolvedReport published in honor of National Eosinophil Awareness Week May 2023 Washington D.C., May 18, 2023 — A groundbreaking study report reveals challenges and barriers to timely diagnosis and effective treatment and management of a rare,...
31 Days of Action During Asthma and Allergy Awareness Month
Get InvolvedAAFA highlights ways people with asthma and allergies can breathe easier in May and beyond Washington, D. C., April 25, 2023 – The Asthma and Allergy Foundation of America (AAFA) is honoring Asthma and Allergy Awareness Month this May...
AAFA Promotes Health Equity and Improves Accessibility and Support With New Websites
Get InvolvedThe world’s oldest asthma and allergy nonprofit organization celebrates 70 years of research, education, advocacy, and community outreach. WASHINGTON D.C., January 12, 2023 — In celebration of its 70th anniversary in 2023, the Asthma and...
Elijah’s Law Report Finds Major Gaps in Child Care Policies for Food Allergy Nationwide
Get InvolvedFOR IMMEDIATE RELEASE The report evaluates child care policies in U.S. states and territories and includes an advocacy toolkit to promote Elijah’s Law to strengthen protections for young children. WASHINGTON D.C., Feb. 25, 2022 — Today,...
